Glenmede Trust’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.98M | Sell |
41,493
-13,154
| -24% | -$1.01M | 0.01% | 511 |
|
|
2025
Q4 | $4.34M | Buy |
+54,647
| New | +$4.31M | 0.02% | 456 |
|
|
2025
Q1 | $4.77M | Sell |
70,402
-10,955
| -13% | -$656K | 0.03% | 428 |
|
|
2024
Q4 | $3.65M | Sell |
81,357
-95,192
| -54% | -$5.34M | 0.02% | 452 |
|
|
2024
Q3 | $11.1M | Sell |
176,549
-156,241
| -47% | -$9.12M | 0.05% | 349 |
|
|
2024
Q2 | $19.7M | Sell |
332,790
-281,843
| -46% | -$17.6M | 0.1% | 202 |
|
|
2024
Q1 | $49M | Sell |
614,633
-4,596
| -0.7% | -$351K | 0.25% | 94 |
|
|
2023
Q4 | $48.9M | Sell |
619,229
-73,309
| -11% | -$5.22M | 0.25% | 95 |
|
|
2023
Q3 | $48.4M | Sell |
692,538
-17,644
| -2% | -$1.25M | 0.28% | 95 |
|
|
2023
Q2 | $52.8M | Sell |
710,182
-359
| -0.1% | -$25.5K | 0.3% | 89 |
|
|
2023
Q1 | $52.8M | Buy |
710,541
+2,605
| +0.4% | +$218K | 0.3% | 89 |
|
|
2022
Q4 | $66M | Buy |
707,936
+6,920
| +1% | +$668K | 0.39% | 72 |
|
|
2022
Q3 | $66.9M | Buy |
701,016
+13,623
| +2% | +$1.35M | 0.42% | 60 |
|
|
2022
Q2 | $63.7M | Sell |
687,393
-2,400
| -0.3% | -$234K | 0.37% | 69 |
|
|
2022
Q1 | $69.8M | Buy |
689,793
+11,358
| +2% | +$1.19M | 0.34% | 74 |
|
|
2021
Q4 | $70M | Buy |
678,435
+3,791
| +0.6% | +$350K | 0.33% | 77 |
|
|
2021
Q3 | $57.2M | Buy |
674,644
+4,254
| +0.6% | +$356K | 0.3% | 90 |
|
|
2021
Q2 | $55.9M | Sell |
670,390
-27,561
| -4% | -$2.26M | 0.29% | 89 |
|
|
2021
Q1 | $52.5M | Buy |
697,951
+14,438
| +2% | +$1.05M | 0.28% | 93 |
|
|
2020
Q4 | $46.7M | Buy |
683,513
+169,106
| +33% | +$11M | 0.26% | 106 |
|
|
2020
Q3 | $30M | Sell |
514,407
-5,749
| -1% | -$358K | 0.18% | 136 |
|
|
2020
Q2 | $33.8M | Buy |
520,156
+58,980
| +13% | +$3.71M | 0.21% | 119 |
|
|
2020
Q1 | $34.3M | Hold |
461,176
| – | – | 0.16% | 182 |
|
|
2019
Q4 | $34.3M | Buy |
461,176
+14,461
| +3% | +$1.02M | 0.16% | 182 |
|
|
2019
Q3 | $28.2K | Buy |
446,715
+24,050
| +6% | +$1.43M | 0.13% | 216 |
|
|
2019
Q2 | $23K | Sell |
422,665
-204,593
| -33% | -$11M | 0.1% | 278 |
|
|
2019
Q1 | $33.8K | Sell |
627,258
-166,649
| -21% | -$10.3M | 0.15% | 206 |
|
|
2018
Q4 | $52K | Buy |
793,907
+133,770
| +20% | +$9.99M | 0.25% | 109 |
|
|
2018
Q3 | $52M | Buy |
660,137
+268,110
| +68% | +$19.2M | 0.21% | 138 |
|
|
2018
Q2 | $25.2M | Sell |
392,027
-96,985
| -20% | -$6.39M | 0.11% | 267 |
|
|
2018
Q1 | $35.5M | Hold |
489,012
| – | – | 0.15% | 209 |
|
|
2017
Q4 | $35.5M | Buy |
489,012
+229,723
| +89% | +$16.7M | 0.15% | 209 |
|
|
2017
Q3 | $21.1M | Buy |
259,289
+22,500
| +10% | +$1.78M | 0.09% | 282 |
|
|
2017
Q2 | $18.6M | Hold |
236,789
| – | – | 0.09% | 301 |
|
|
2017
Q1 | $18.6M | Sell |
236,789
-11,202
| -5% | -$894K | 0.09% | 301 |
|
|
2016
Q4 | $19.6M | Sell |
247,991
-116,000
| -32% | -$9.39M | 0.11% | 293 |
|
|
2016
Q3 | $32.4M | Sell |
363,991
-234,168
| -39% | -$22.1M | 0.18% | 181 |
|
|
2016
Q2 | $57.3M | Sell |
598,159
-35,595
| -6% | -$3.55M | 0.35% | 71 |
|
|
2016
Q1 | $65.7M | Sell |
633,754
-148,935
| -19% | -$14.5M | 0.43% | 52 |
|
|
2015
Q4 | $76.5M | Buy |
782,689
+477,245
| +156% | +$46.7M | 0.52% | 38 |
|
|
2015
Q3 | $29.5M | Buy |
305,444
+32,802
| +12% | +$3.45M | 0.22% | 145 |
|
|
2015
Q2 | $28.6M | Buy |
272,642
+6,752
| +3% | +$690K | 0.21% | 156 |
|
|
2015
Q1 | $27.4M | Sell |
265,890
-5,642
| -2% | -$571K | 0.2% | 152 |
|
|
2014
Q4 | $26.1M | Buy |
271,532
+3,125
| +1% | +$275K | 0.2% | 149 |
|
|
2014
Q3 | $21.4M | Buy |
268,407
+17,525
| +7% | +$1.38M | 0.19% | 160 |
|
|
2014
Q2 | $18.9M | Sell |
250,882
-5,166
| -2% | -$390K | 0.17% | 180 |
|
|
2014
Q1 | $19.2M | Buy |
256,048
+36,801
| +17% | +$2.6M | 0.18% | 138 |
|
|
2013
Q4 | $15.7M | Sell |
219,247
-4,736
| -2% | -$304K | 0.16% | 156 |
|
|
2013
Q3 | $12.7M | Sell |
223,983
-2,998
| -1% | -$179K | 0.15% | 165 |
|
|
2013
Q2 | $13M | Buy |
+226,981
| New | +$13.2M | 0.16% | 134 |
|
Other funds holding CVS
VCM
VPM
Glenmede Trust's CVS Position: Q1 2026 in Review
Glenmede Trust reduced its CVS Health (CVS) stake by 24% in Q1 2026, selling an estimated $1.01M and leaving 41,493 shares worth $2.98M. The position accounts for 0.01% of the portfolio, ranked #511.
Glenmede Trust first reported a position in CVS in Q2 2013 and has held it in 50 quarters since. The position peaked at $76.5M in Q4 2015. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Glenmede Trust held 41,493 shares of CVS Health worth $2.98M as of Q1 2026.
- Glenmede Trust sold 13,154 CVS Health shares in Q1 2026, an estimated $1.01M.
- CVS Health made up 0.01% of Glenmede Trust's portfolio in Q1 2026, its #511 holding.
- Glenmede Trust first reported a position in CVS Health in Q2 2013 and has held it in 50 quarters since.
- Glenmede Trust's CVS Health position peaked at $76.5M in Q4 2015.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.